Kidney cancer trials in Germany

In Germany 19 Also abroad 485

19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Augsburg, Berlin, Heidelberg, Jena, Munich
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
No phaseTaking people
Registry Platform Urologic Cancer
Where
Multiple Locations
Age
18 years and over
People
2,230
Run by
iOMEDICO AG
See details and how to joinNCT03374267
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Berlin, Dresden, Essen, Frankfurt am Main, Freiburg im Breisgau, Halle Saale, Hanover, Heidelberg, Leipzig, Luebeck, Marburg, Rostock, Ulm
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
No phaseNot yet taking people in Germany
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Where
Berlin, München
People
50 worldwide
Run by
Aristotle University Of Thessaloniki
See details and how to joinNCT07888322
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Where
Hamburg, Herne, Jena, Munich
Age
18 years and over
People
474 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00
Phase 1Taking people
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Where
Berlin, Ulm, Wuerzburg
Age
18 years and over
People
300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00
Phase 1/2Taking people
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Where
Berlin, Dresden, Essen, Heidelberg
Age
18 years and over
People
224 worldwide
Run by
Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Magdeburg
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Essen, Heidelberg, Herne, Jena, Nuertingen, Tuebingen
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 1Not yet taking people in Germany
A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Essen, Jena
Age
18 years and over
People
112 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295
Phase 3Taking people
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Where
Duesseldorf, Essen, Frankfurt Am Main, Hanover, Heidelberg, Herne, Munich, Münster, Stuttgart, Tübingen
Age
18 years and over
People
1,373 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-503317-29-00 · EU 2023-503317-29-00
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
Hamburg, Heilbronn, Munich
Age
18 years and over
People
2,285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
No phaseTaking people
Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
Where
Leipzig
Age
18 years and over
People
60
Run by
University of Leipzig
See details and how to joinNCT07803315
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Dresden, Essen, Frankfurt, Ulm, Würzburg
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 3Taking people
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Where
Berlin, Dresden, Erfurt, Goettingen, Hamburg, Herne, Jena, Muenster, Nuertingen, Rostock, Schwerin, Stuttgart, Tuebingen
Age
18 years and over
People
904 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00
Phase 1/2Taking people
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Where
Bonn, Erlangen, Essen, Hamburg, Heilbronn
Age
18 years and over
People
240 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00
No phaseNot yet taking people in Germany
Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
Where
Heidelberg
Age
18 years and over
People
600 worldwide
Run by
OncoHost Ltd.
See details and how to joinNCT07246759
No phaseTaking people
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Where
Erlangen
Age
18 years and over
People
200
Run by
University of Erlangen-Nürnberg Medical School
See details and how to joinNCT04892849
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Hamburg
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767